カテゴリー： Market Monitor Global, 世界, 医療/バイオ

眼科用抗炎症薬の世界市場見通し2023年-2029年

◆英語タイトル：Ophthalmic Anti-inflammatories Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5832）◆商品コード：MMG23JU5832
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：76
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Ophthalmic Anti-inflammatories Market 調査レポートは次の情報を含め、グローバルにおけるの眼科用抗炎症薬市場規模と予測を収録しています。・世界の眼科用抗炎症薬市場：売上、2018年-2023年、2024年-2029年
・世界の眼科用抗炎症薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の眼科用抗炎症薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗菌」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

眼科用抗炎症薬のグローバル主要企業は、Novartis、 Valeant Pharmaceuticals、 Allergan、 Santen Pharmaceutical、 Lupin Pharmaceuticals、 Apotex、 Akornなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、眼科用抗炎症薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の眼科用抗炎症薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の眼科用抗炎症薬市場：タイプ別市場シェア、2022年
・抗菌、抗ウイルス、抗真菌、抗寄生虫、その他

世界の眼科用抗炎症薬市場：用途別、2018年-2023年、2024年-2029年
世界の眼科用抗炎症薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の眼科用抗炎症薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の眼科用抗炎症薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における眼科用抗炎症薬のグローバル売上、2018年-2023年
・主要企業における眼科用抗炎症薬のグローバル売上シェア、2022年
・主要企業における眼科用抗炎症薬のグローバル販売量、2018年-2023年
・主要企業における眼科用抗炎症薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis、 Valeant Pharmaceuticals、 Allergan、 Santen Pharmaceutical、 Lupin Pharmaceuticals、 Apotex、 Akorn

*************************************************************

・調査・分析レポートの概要
眼科用抗炎症薬市場の定義
市場セグメント
世界の眼科用抗炎症薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の眼科用抗炎症薬市場規模
世界の眼科用抗炎症薬市場規模：2022年 VS 2029年
世界の眼科用抗炎症薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの眼科用抗炎症薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の眼科用抗炎症薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗菌、抗ウイルス、抗真菌、抗寄生虫、その他
眼科用抗炎症薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
眼科用抗炎症薬の用途別グローバル売上・予測

・地域別市場分析
地域別眼科用抗炎症薬市場規模 2022年と2029年
地域別眼科用抗炎症薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Valeant Pharmaceuticals、 Allergan、 Santen Pharmaceutical、 Lupin Pharmaceuticals、 Apotex、 Akorn
...

This report aims to provide a comprehensive presentation of the global market for Ophthalmic Anti-inflammatories, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Anti-inflammatories. This report contains market size and forecasts of Ophthalmic Anti-inflammatories in global, including the following market information:
Global Ophthalmic Anti-inflammatories Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ophthalmic Anti-inflammatories Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Ophthalmic Anti-inflammatories companies in 2022 (%)
The global Ophthalmic Anti-inflammatories market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Antibacterial Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ophthalmic Anti-inflammatories include Novartis, Valeant Pharmaceuticals, Allergan, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ophthalmic Anti-inflammatories manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Anti-inflammatories Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmic Anti-inflammatories Market Segment Percentages, by Type, 2022 (%)
Antibacterial
Antiviral
Antifungal
Anti-Parasitic
Others
Global Ophthalmic Anti-inflammatories Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmic Anti-inflammatories Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Ophthalmic Anti-inflammatories Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmic Anti-inflammatories Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Anti-inflammatories revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ophthalmic Anti-inflammatories revenues share in global market, 2022 (%)
Key companies Ophthalmic Anti-inflammatories sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Ophthalmic Anti-inflammatories sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Valeant Pharmaceuticals
Allergan
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Anti-inflammatories, market overview.
Chapter 2: Global Ophthalmic Anti-inflammatories market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmic Anti-inflammatories manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Anti-inflammatories in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmic Anti-inflammatories capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Anti-inflammatories Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Anti-inflammatories Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Anti-inflammatories Overall Market Size
2.1 Global Ophthalmic Anti-inflammatories Market Size: 2022 VS 2029
2.2 Global Ophthalmic Anti-inflammatories Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ophthalmic Anti-inflammatories Sales: 2018-2029
3 Company Landscape
3.1 Top Ophthalmic Anti-inflammatories Players in Global Market
3.2 Top Global Ophthalmic Anti-inflammatories Companies Ranked by Revenue
3.3 Global Ophthalmic Anti-inflammatories Revenue by Companies
3.4 Global Ophthalmic Anti-inflammatories Sales by Companies
3.5 Global Ophthalmic Anti-inflammatories Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ophthalmic Anti-inflammatories Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ophthalmic Anti-inflammatories Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ophthalmic Anti-inflammatories Players in Global Market
3.8.1 List of Global Tier 1 Ophthalmic Anti-inflammatories Companies
3.8.2 List of Global Tier 2 and Tier 3 Ophthalmic Anti-inflammatories Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Ophthalmic Anti-inflammatories Market Size Markets, 2022 & 2029
4.1.2 Antibacterial
4.1.3 Antiviral
4.1.4 Antifungal
4.1.5 Anti-Parasitic
4.1.6 Others
4.2 By Type – Global Ophthalmic Anti-inflammatories Revenue & Forecasts
4.2.1 By Type – Global Ophthalmic Anti-inflammatories Revenue, 2018-2023
4.2.2 By Type – Global Ophthalmic Anti-inflammatories Revenue, 2024-2029
4.2.3 By Type – Global Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
4.3 By Type – Global Ophthalmic Anti-inflammatories Sales & Forecasts
4.3.1 By Type – Global Ophthalmic Anti-inflammatories Sales, 2018-2023
4.3.2 By Type – Global Ophthalmic Anti-inflammatories Sales, 2024-2029
4.3.3 By Type – Global Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
4.4 By Type – Global Ophthalmic Anti-inflammatories Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Ophthalmic Anti-inflammatories Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Ophthalmic Anti-inflammatories Revenue & Forecasts
5.2.1 By Application – Global Ophthalmic Anti-inflammatories Revenue, 2018-2023
5.2.2 By Application – Global Ophthalmic Anti-inflammatories Revenue, 2024-2029
5.2.3 By Application – Global Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
5.3 By Application – Global Ophthalmic Anti-inflammatories Sales & Forecasts
5.3.1 By Application – Global Ophthalmic Anti-inflammatories Sales, 2018-2023
5.3.2 By Application – Global Ophthalmic Anti-inflammatories Sales, 2024-2029
5.3.3 By Application – Global Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
5.4 By Application – Global Ophthalmic Anti-inflammatories Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Ophthalmic Anti-inflammatories Market Size, 2022 & 2029
6.2 By Region – Global Ophthalmic Anti-inflammatories Revenue & Forecasts
6.2.1 By Region – Global Ophthalmic Anti-inflammatories Revenue, 2018-2023
6.2.2 By Region – Global Ophthalmic Anti-inflammatories Revenue, 2024-2029
6.2.3 By Region – Global Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
6.3 By Region – Global Ophthalmic Anti-inflammatories Sales & Forecasts
6.3.1 By Region – Global Ophthalmic Anti-inflammatories Sales, 2018-2023
6.3.2 By Region – Global Ophthalmic Anti-inflammatories Sales, 2024-2029
6.3.3 By Region – Global Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Ophthalmic Anti-inflammatories Revenue, 2018-2029
6.4.2 By Country – North America Ophthalmic Anti-inflammatories Sales, 2018-2029
6.4.3 US Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.4.4 Canada Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.4.5 Mexico Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Ophthalmic Anti-inflammatories Revenue, 2018-2029
6.5.2 By Country – Europe Ophthalmic Anti-inflammatories Sales, 2018-2029
6.5.3 Germany Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.4 France Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.5 U.K. Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.6 Italy Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.7 Russia Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.8 Nordic Countries Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.9 Benelux Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Ophthalmic Anti-inflammatories Revenue, 2018-2029
6.6.2 By Region – Asia Ophthalmic Anti-inflammatories Sales, 2018-2029
6.6.3 China Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.6.4 Japan Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.6.5 South Korea Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.6.6 Southeast Asia Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.6.7 India Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Ophthalmic Anti-inflammatories Revenue, 2018-2029
6.7.2 By Country – South America Ophthalmic Anti-inflammatories Sales, 2018-2029
6.7.3 Brazil Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.7.4 Argentina Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Ophthalmic Anti-inflammatories Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Ophthalmic Anti-inflammatories Sales, 2018-2029
6.8.3 Turkey Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.8.4 Israel Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.8.5 Saudi Arabia Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.8.6 UAE Ophthalmic Anti-inflammatories Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Ophthalmic Anti-inflammatories Major Product Offerings
7.1.4 Novartis Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Valeant Pharmaceuticals
7.2.1 Valeant Pharmaceuticals Company Summary
7.2.2 Valeant Pharmaceuticals Business Overview
7.2.3 Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Major Product Offerings
7.2.4 Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.2.5 Valeant Pharmaceuticals Key News & Latest Developments
7.3 Allergan
7.3.1 Allergan Company Summary
7.3.2 Allergan Business Overview
7.3.3 Allergan Ophthalmic Anti-inflammatories Major Product Offerings
7.3.4 Allergan Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.3.5 Allergan Key News & Latest Developments
7.4 Santen Pharmaceutical
7.4.1 Santen Pharmaceutical Company Summary
7.4.2 Santen Pharmaceutical Business Overview
7.4.3 Santen Pharmaceutical Ophthalmic Anti-inflammatories Major Product Offerings
7.4.4 Santen Pharmaceutical Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.4.5 Santen Pharmaceutical Key News & Latest Developments
7.5 Lupin Pharmaceuticals
7.5.1 Lupin Pharmaceuticals Company Summary
7.5.2 Lupin Pharmaceuticals Business Overview
7.5.3 Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Major Product Offerings
7.5.4 Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.5.5 Lupin Pharmaceuticals Key News & Latest Developments
7.6 Apotex
7.6.1 Apotex Company Summary
7.6.2 Apotex Business Overview
7.6.3 Apotex Ophthalmic Anti-inflammatories Major Product Offerings
7.6.4 Apotex Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.6.5 Apotex Key News & Latest Developments
7.7 Akorn
7.7.1 Akorn Company Summary
7.7.2 Akorn Business Overview
7.7.3 Akorn Ophthalmic Anti-inflammatories Major Product Offerings
7.7.4 Akorn Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.7.5 Akorn Key News & Latest Developments
8 Global Ophthalmic Anti-inflammatories Production Capacity, Analysis
8.1 Global Ophthalmic Anti-inflammatories Production Capacity, 2018-2029
8.2 Ophthalmic Anti-inflammatories Production Capacity of Key Manufacturers in Global Market
8.3 Global Ophthalmic Anti-inflammatories Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ophthalmic Anti-inflammatories Supply Chain Analysis
10.1 Ophthalmic Anti-inflammatories Industry Value Chain
10.2 Ophthalmic Anti-inflammatories Upstream Market
10.3 Ophthalmic Anti-inflammatories Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ophthalmic Anti-inflammatories Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Ophthalmic Anti-inflammatories in Global Market
Table 2. Top Ophthalmic Anti-inflammatories Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Ophthalmic Anti-inflammatories Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Ophthalmic Anti-inflammatories Revenue Share by Companies, 2018-2023
Table 5. Global Ophthalmic Anti-inflammatories Sales by Companies, (K Units), 2018-2023
Table 6. Global Ophthalmic Anti-inflammatories Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Ophthalmic Anti-inflammatories Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Ophthalmic Anti-inflammatories Product Type
Table 9. List of Global Tier 1 Ophthalmic Anti-inflammatories Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmic Anti-inflammatories Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Ophthalmic Anti-inflammatories Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Ophthalmic Anti-inflammatories Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Ophthalmic Anti-inflammatories Sales (K Units), 2018-2023
Table 15. By Type - Global Ophthalmic Anti-inflammatories Sales (K Units), 2024-2029
Table 16. By Application – Global Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Ophthalmic Anti-inflammatories Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Ophthalmic Anti-inflammatories Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Ophthalmic Anti-inflammatories Sales (K Units), 2018-2023
Table 20. By Application - Global Ophthalmic Anti-inflammatories Sales (K Units), 2024-2029
Table 21. By Region – Global Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Ophthalmic Anti-inflammatories Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Ophthalmic Anti-inflammatories Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Ophthalmic Anti-inflammatories Sales (K Units), 2018-2023
Table 25. By Region - Global Ophthalmic Anti-inflammatories Sales (K Units), 2024-2029
Table 26. By Country - North America Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Ophthalmic Anti-inflammatories Sales, (K Units), 2018-2023
Table 29. By Country - North America Ophthalmic Anti-inflammatories Sales, (K Units), 2024-2029
Table 30. By Country - Europe Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Ophthalmic Anti-inflammatories Sales, (K Units), 2018-2023
Table 33. By Country - Europe Ophthalmic Anti-inflammatories Sales, (K Units), 2024-2029
Table 34. By Region - Asia Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Ophthalmic Anti-inflammatories Sales, (K Units), 2018-2023
Table 37. By Region - Asia Ophthalmic Anti-inflammatories Sales, (K Units), 2024-2029
Table 38. By Country - South America Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Ophthalmic Anti-inflammatories Sales, (K Units), 2018-2023
Table 41. By Country - South America Ophthalmic Anti-inflammatories Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Ophthalmic Anti-inflammatories Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Ophthalmic Anti-inflammatories Sales, (K Units), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Ophthalmic Anti-inflammatories Product Offerings
Table 48. Novartis Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Valeant Pharmaceuticals Company Summary
Table 51. Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Product Offerings
Table 52. Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Valeant Pharmaceuticals Key News & Latest Developments
Table 54. Allergan Company Summary
Table 55. Allergan Ophthalmic Anti-inflammatories Product Offerings
Table 56. Allergan Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Allergan Key News & Latest Developments
Table 58. Santen Pharmaceutical Company Summary
Table 59. Santen Pharmaceutical Ophthalmic Anti-inflammatories Product Offerings
Table 60. Santen Pharmaceutical Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Santen Pharmaceutical Key News & Latest Developments
Table 62. Lupin Pharmaceuticals Company Summary
Table 63. Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Product Offerings
Table 64. Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Lupin Pharmaceuticals Key News & Latest Developments
Table 66. Apotex Company Summary
Table 67. Apotex Ophthalmic Anti-inflammatories Product Offerings
Table 68. Apotex Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Apotex Key News & Latest Developments
Table 70. Akorn Company Summary
Table 71. Akorn Ophthalmic Anti-inflammatories Product Offerings
Table 72. Akorn Ophthalmic Anti-inflammatories Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Akorn Key News & Latest Developments
Table 74. Ophthalmic Anti-inflammatories Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Ophthalmic Anti-inflammatories Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Ophthalmic Anti-inflammatories Production by Region, 2018-2023 (K Units)
Table 77. Global Ophthalmic Anti-inflammatories Production by Region, 2024-2029 (K Units)
Table 78. Ophthalmic Anti-inflammatories Market Opportunities & Trends in Global Market
Table 79. Ophthalmic Anti-inflammatories Market Drivers in Global Market
Table 80. Ophthalmic Anti-inflammatories Market Restraints in Global Market
Table 81. Ophthalmic Anti-inflammatories Raw Materials
Table 82. Ophthalmic Anti-inflammatories Raw Materials Suppliers in Global Market
Table 83. Typical Ophthalmic Anti-inflammatories Downstream
Table 84. Ophthalmic Anti-inflammatories Downstream Clients in Global Market
Table 85. Ophthalmic Anti-inflammatories Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ophthalmic Anti-inflammatories Segment by Type in 2022
Figure 2. Ophthalmic Anti-inflammatories Segment by Application in 2022
Figure 3. Global Ophthalmic Anti-inflammatories Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ophthalmic Anti-inflammatories Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Ophthalmic Anti-inflammatories Revenue, 2018-2029 (US$, Mn)
Figure 7. Ophthalmic Anti-inflammatories Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Ophthalmic Anti-inflammatories Revenue in 2022
Figure 9. By Type - Global Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
Figure 11. By Type - Global Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
Figure 12. By Type - Global Ophthalmic Anti-inflammatories Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
Figure 15. By Application - Global Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
Figure 16. By Application - Global Ophthalmic Anti-inflammatories Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Ophthalmic Anti-inflammatories Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
Figure 20. By Region - Global Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
Figure 21. By Country - North America Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
Figure 22. By Country - North America Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
Figure 23. US Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
Figure 28. Germany Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 29. France Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
Figure 37. China Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 41. India Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
Figure 43. By Country - South America Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
Figure 44. Brazil Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
Figure 48. Turkey Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Ophthalmic Anti-inflammatories Revenue, (US$, Mn), 2018-2029
Figure 52. Global Ophthalmic Anti-inflammatories Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Ophthalmic Anti-inflammatories by Region, 2022 VS 2029
Figure 54. Ophthalmic Anti-inflammatories Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 眼科用抗炎症薬の世界市場見通し2023年-2029年(Ophthalmic Anti-inflammatories Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 眼科疾患治療薬の世界市場2022年～2029年：薬物クラス別、剤形別、疾患別、流通チャネル別、地域別
  • 抗肥満薬の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆